This came after the drug major Sun Pharma Laboratories presented the proposal to conduct Phase III clinical trial titled “A ...
Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q3 2025 Earnings Call October 22, 2025 4:30 PM EDT Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator ...
Discusses Updated Monotherapy Phase I Data for Suzhou and Outlines Next Steps in Clinical Development October 24, 2025 ...
Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that ...
Farmers are meticulous about all sorts of monitoring but many still overlook the quality of the water they use in irrigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback